Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cagent Vascular
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cagent Vascular

Cagent Vascular

Series A

Cagent Vascular: US-based medical device manufacturer specializing in cardiovascular disease treatment.

HQ
Wayne, PA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Cagent Vascular is a US-based medical device manufacturer specializing in the treatment of cardiovascular disease. The company pioneers serration technology aimed at improving blood flow and overall cardiovascular health. Their flagship product, the Serranator® PTA Serration Balloon Catheter, simplifies lumen gain and effectively treats various lesion morphologies, regardless of location or type. Cagent Vascular focuses on providing advanced solutions for peripheral artery disease.

Cagent Vascular has made significant strides in the medical device industry with its innovative serration technology. The Serranator® has been well-received by clinicians for its ability to treat complex lesions efficiently, enhancing patient outcomes. The company's impact is evident in its contribution to improving cardiovascular treatments and restoring quality of life for patients with peripheral artery disease.

Cagent Vascular - Similar Companies

Advanced Catheter Therapies logo

Advanced Catheter Therapies

acatheter.com

Traverse Vascular logo

Traverse Vascular

Cross Vascular logo

Cross Vascular

Bluegrass Vascular Technologies logo

Bluegrass Vascular Technologies

Vascugenix logo

Vascugenix

vascugenix.com

Vascular Designs logo

Vascular Designs

Attwill Vascular Technologies logo

Attwill Vascular Technologies

R3 Vascular logo

R3 Vascular

r3vascular.com

Vascular Dynamics logo

Vascular Dynamics

Venarum Medical logo

Venarum Medical

Access Vascular logo

Access Vascular

Capture Vascular logo

Capture Vascular

SonoVascular logo

SonoVascular

sonovascular.com

Avinger logo

Avinger

avinger.com

Saphena Medical logo

Saphena Medical

saphenamedical.com

Cagent Vascular - Quick Facts

Who are Cagent Vascular's competitors?

Companies similar to Cagent Vascular include Advanced Catheter Therapies, Traverse Vascular, Cross Vascular and Bluegrass Vascular Technologies.

When was Cagent Vascular founded?

Cagent Vascular was founded in 2014.

Where is Cagent Vascular's headquarters located?

Cagent Vascular's headquarters is located in Wayne, PA, US.

When was Cagent Vascular's last funding round?

Cagent Vascular's most recent funding round was for $9.5M (USD) in June 2021.

How much has Cagent Vascular raised to-date?

As of Jun 23, 2021, Cagent Vascular has raised a total of $21.9M (USD).

How many employees does Cagent Vascular have?

Cagent Vascular has 41 employees as of Feb 5, 2024.

Cagent Vascular - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
  • Medical
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified